Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MAOA | P21397 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | APEX1 | P27695 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoquinone SCHEMBL28410312 | 0.93 | ADORA2A (0.47) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL22233093 | 0.92 | MEN1 (0.50) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL22233095 | 0.92 | ADORA2A (0.53) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL10732300 | 0.89 | MEN1 (0.60) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL14129454 | 0.82 | S100A4 (0.55) | ALDH1A1MAPTL3MBTL1MEN1KMT2A | |
| SCHEMBL8613053 | 0.82 | CYP1A2 (0.46) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL10340740 | 0.80 | ALDH1A1 (0.62) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL10889334 | 0.80 | MAPT (0.47) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL6560760 | 0.80 | MEN1 (0.67) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 | |
| SCHEMBL8777879 | 0.80 | MAOA (0.67) | ADORA2AALDH1A1MAPTL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035839-A1 | CHEMICAL COMPOUND CAPTURE SYSTEM AND METHOD | CARBON HOLDINGS INTELLECTUAL PROPERTIES LLC (US) | 2026-02-05 | — | — | US | claimed |
| CN-119463526-A | Preparation method of high-coverage yellow-phase quinacridone pigment | 连云港海迪化工科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-221619345-U | High concentration dichloro anthraquinone solution dilutes cauldron | 唐山周行科技发展有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-115197082-B | Anthraquinone diamine monomer, magenta intrinsic polyimide derived from anthraquinone diamine monomer and preparation method of magenta intrinsic polyimide | 上海交通大学 | 2023-09-22 | — | — | CN | claimed |
| EP-4157967-A1 | SYSTEMS AND METHODS FOR MANUFACTURING LOW-DENSITY CARBON FIBER FROM COAL | Ramaco Carbon, LLC (US) | 2023-04-05 | — | — | EP | claimed |
| CN-112770632-B | Fungicidal compositions | 先正达农作物保护股份公司 | 2022-12-27 | — | — | CN | claimed |
| CN-115197082-A | Anthraquinone-based diamine monomer, magenta intrinsic polyimide derived from same and preparation method thereof | 上海交通大学 | 2022-10-18 | — | — | CN | claimed |
| US-20210372010-A1 | SYSTEMS AND METHODS FOR MANUFACTURING LOW-DENSITY CARBON FIBER FROM COAL | CARBON HOLDINGS INTELLECTUAL PROPERTIES, LLC | 2021-12-02 | — | — | US | claimed |
| WO-2021243338-A1 | SYSTEMS AND METHODS FOR MANUFACTURING LOW-DENSITY CARBON FIBER FROM COAL | RAMACO CARBON, LLC (US) | 2021-12-02 | — | — | WO | claimed |
| CN-109897311-B | Anthraquinone polymer-based composite dielectric material and preparation method thereof | 武汉理工大学 | 2020-08-04 | — | — | CN | claimed |
| US-5286863-A | Catalytic oxidation of substituted 6,13-dihydroquinacridones | CIBA-GEIGY CORPORATION (US) | 1994-02-15 | — | — | US | claimed |
| EP-0530142-A1 | Oxidation process for preparing quinacridone pigments | CIBA-GEIGY AG (CH) | 1993-03-03 | — | — | EP | claimed |
| EP-0417794-A2 | Liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 1991-03-20 | — | — | EP | claimed |
| EP-0136981-B1 | PROCESS FOR THE PREPARATION OF ANTHRAQUINONE IMIDE COMPOUNDS | CIBA-GEIGY AG (CH) | 1989-04-05 | — | — | EP | claimed |
| US-4659831-A | Process for the preparation of anthraquinone imides | CIBA-GEIGY AG (CH) | 1987-04-21 | — | — | US | claimed |
| EP-0136981-A2 | Process for the preparation of anthraquinone imide compounds | CIBA-GEIGY AG (CH) | 1985-04-10 | — | — | EP | claimed |
| EP-0106923-A1 | Improved water-in-oil emulsion explosives and a method for the preparation of the same | INDIAN EXPLOSIVES LIMITED (IN) | 1984-05-02 | — | — | EP | claimed |
| US-4279825-A | Process for the preparation of 1,4-diaminoanthraquinone-2,3-disulphonic acid | BAYER AKTIENGESELLSCHAFT (DE) | 1981-07-21 | — | — | US | claimed |
| US-4179450-A | Process for the preparation of 1-acylamino-5(8)-chloroanthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-18 | — | — | US | claimed |
| US-4162946-A | Process for concentrating halogenoanthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035839-A1 | CHEMICAL COMPOUND CAPTURE SYSTEM AND METHOD | RDX, MARK4, RALA | ADORA2A 3521/4885ALDH1A1 3173/4885MAPT 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.